TCTAP A-066 Neo-Atherosclerosis in Drug-eluting Stents Is the Risk of Recurrent Restenosis
نویسندگان
چکیده
منابع مشابه
Restenosis and drug-eluting stents.
The implantation of intracoronary stents for the treatment of coronary atherosclerotic disease is one of the most common percutaneous procedures. While the procedure brings long-term benefit for a large percentage of patients, a significant number of patients experience in-stent restenosis (ISR). ISR may be caused by a number of biological and procedural factors, including lesion characteristic...
متن کاملDrug-eluting stents: the end of restenosis?
One of the major advancements in interventional cardiology has been the introduction of drug-eluting stents (DES). By incorporating anti-proliferative agents onto the surface of the stent, neointimal hyperplasia occurring within the stent, which is the main cause of in-stent restenosis (ISR), is markedly reduced. Stents coated with agents, like sirolimus or paclitaxel, when compared to bare met...
متن کاملIncidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
OBJECTIVES We investigated the incidence and predictors of recurrent restenosis after drug-eluting stent (DES) implantation for in-stent restenosis (ISR) in routine clinical practice. BACKGROUND Although DESs have been increasingly used for treatment of ISR, little is known about the predictors of DES failure. METHODS We determined the incidence of recurrent restenosis and major adverse car...
متن کاملIntracoronary brachytherapy for in-stent restenosis of drug-eluting stents
PURPOSE Given the limited salvage options for in-stent restenosis (ISR) of drug-eluting stents (DES), our high-volume cardiac catheterization laboratory has been performing intracoronary brachytherapy (ICBT) in patients with recurrent ISR of DES. This study analyzes their baseline characteristics and assesses the safety/toxicity of ICBT in this high-risk population. METHODS AND MATERIALS A re...
متن کاملDrug Eluting Stents – Do They Address the Problem of Restenosis?
Percutaneous coronary intervention (PCI) has revolutionised the treatment of coronary artery disease, which remains one of the major causes of mortality in developed nations throughout the world. It is used to treat patients with both stable angina and acute coronary syndromes, and is also the treatment of choice in acute STelevation myocardial infarction. PCI is popular with patients when comp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2014
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2014.02.082